Hoda Salem | Clinical Trials | Best Researcher Award

Published on by Top Pharmaceutical

Hoda Salem | Clinical Trials | Best Researcher Award

Prof. Dr. Hoda Salem, University of Tabuk, Saudi Arabia

Prof. Dr. Hoda Salem 🎓 is a distinguished clinical pharmacy expert with a Ph.D. in Pharmaceutical Sciences from Tanta University, Egypt 🇪🇬. With over two decades of academic and clinical experience, she currently serves as Professor at Tabuk University, Saudi Arabia 🇸🇦. She has led numerous funded research projects, particularly in neuropharmacology and pharmacogenetics 🧬🧠. A prolific scholar, Dr. Salem has published in Q1 journals 📚 and actively mentors Ph.D. and MSc students. Her contributions extend to curriculum development, hospital training, and quality assurance in education 🌍. She’s a driving force in pharmacy education and clinical research excellence.

Publication Profile

Google Scholar

Education

Prof. Dr. Hoda Salem 🎓 earned her Bachelor’s degree in Pharmaceutical Sciences from Tanta University, Egypt 🇪🇬. She continued her academic journey with a Master’s degree (M.Sc.) in Clinical Pharmacy from the same university, demonstrating early on her commitment to specialized healthcare and pharmaceutical practice 💊. Her pursuit of excellence culminated in a Ph.D. in Clinical Pharmacy in 2008 🧪, also from Tanta University. This strong academic foundation laid the groundwork for her impactful career in clinical pharmacy, education, and research, making her a respected figure in both Egyptian and international pharmaceutical education and clinical advancement.

Experience

Prof. Dr. Hoda Salem ⚕️ has made significant contributions to both scientific and clinical work in pharmacy education and healthcare. She played a pivotal role in quality assurance and accreditation by leading the self-study efforts and contributing to strategic planning at Tabuk and Al-Azhar Universities 📊📚. As a committee member, she helped supervise undergraduate examinations and mentored numerous Ph.D. and M.Sc. research projects 🎓🧬. Her clinical work includes patient counseling, drug dispensing, and providing accurate drug information to healthcare professionals at Tanta University Hospitals 💊🏥, reinforcing her commitment to enhancing both education and patient care.

Research Focus

Prof. Dr. Hoda Salem’s 🧪 research focus lies in clinical pharmacy, pharmaceutics, and neuropharmacology with a multidisciplinary approach integrating nanotechnology, drug delivery systems, and natural compounds. Her publications explore the treatment of diseases such as Alzheimer’s 🧠, Parkinson’s, ADHD, and fungal infections, along with oncology 🧬 and pharmacogenetics in breast cancer therapy. She has also worked on innovative therapies like solid lipid nanoparticles, niosomal gels, and bone marrow stem cell applications. Her clinical trials and lab studies reflect a deep commitment to therapeutic innovation, patient care, and translational research 💊🔬, bridging pharmaceutical science and clinical outcomes for better healthcare.

Publication Top Notes

Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study‏

Neuroprotective effects of phytochemicals against aluminum chloride-induced Alzheimer’s disease through ApoE4/LRP1, wnt3/β-catenin/gsk3β, and TLR4/NLRP3 pathways with physical …‏

Neuroprotective effect of morin hydrate against attention-deficit/hyperactivity disorder (ADHD) induced by MSG and/or protein malnutrition in rat pups: Effect on oxidative …‏

Autologous transplantation of CD34+ bone marrow derived mononuclear cells in management of non-reconstructable critical lower limb ischemia‏

A randomized controlled trial evaluating the effects of amlodipine on myocardial iron deposition in pediatric patients with thalassemia major‏

The role of hepatic expression of STAT1, SOCS3 and PIAS1 in the response of chronic hepatitis C patients to therapy‏

Enhancement of zaleplon oral bioavailability using optimized self-nano emulsifying drug delivery systems and its effect on sleep quality among a sample of psychiatric patients‏

Effective method of evaluating myocardial iron concentration in pediatric patients with thalassemia major‏

Formulation, in-vitro and in-vivo evaluation of nystatin topical gel‏

DEVELOPMENT AND CLINICAL EVALUATION OF TOPICAL HYDROQUINONE NIOSOMAL GEL FORMULATION FOR THE TREATMENT OF MELASMA‏

Effect of oral Methyl Prednisolone on different radiological patterns of hypersensitivity pneumonitis‏

Golgem Mehmetoglu | Clinical Trials | Best Researcher Award

Published on by Top Pharmaceutical

Golgem Mehmetoglu | Clinical Trials | Best Researcher Award

Ms. Golgem Mehmetoglu, European University of Lefke, Cyprus

Ms. Gölgem Mehmetoğlu is a dedicated physiotherapist and academic specializing in Physiotherapy and Rehabilitation. 🎓 She earned her B.Sc. from Eastern Mediterranean University (2011–2015), her M.Sc. from European University of Lefke (2015–2017), and is currently pursuing her Ph.D. at EMU. 🧠 Her research focuses on muscle function, postural stability, and rehabilitation outcomes, with multiple publications in international journals and conference proceedings. 📝 She also teaches core courses such as Kinesiology, Biomechanics, and Manual Therapy Techniques. 👩‍🏫 Her scientific contributions and educational roles make her a valuable candidate for the Best Researcher Award.

Publication Profile

Orcid

Education

Ms. Gölgem Mehmetoğlu is a passionate professional in the field of Physiotherapy and Rehabilitation 🧘‍♀️. She completed her undergraduate studies (2011–2015) at Doğu Akdeniz University 🏛️, laying a strong foundation in clinical practice and patient care. She then pursued her Master’s degree (2015–2017) at Lefke Avrupa University 📘, deepening her knowledge in rehabilitation science. Currently, she is advancing her academic journey through a Ph.D. program at Doğu Akdeniz University (2018–present) 🧪. Her academic path reflects commitment to continuous learning and specialization in physiotherapy, contributing to healthcare with evidence-based practice and innovative research.

Academic Positions

Ms. Golgem Mehmetoğlu 🎓 is a dedicated academic in the field of physiotherapy and rehabilitation, actively engaged in teaching at the undergraduate level. She shares her expertise through a variety of core courses including Kinesiology 🤸‍♀️, Biomechanics 🦴, Normal Motor Development 🧠, and Manual Therapy Techniques (Manipulation-Mobilization I & II) 💆‍♀️. Her teaching approach combines theoretical knowledge with hands-on application, empowering students with essential clinical and analytical skills. Through her passionate involvement in education, Ms. Mehmetoğlu continues to inspire future healthcare professionals and contribute meaningfully to the advancement of physiotherapy science.

Research Focus

Ms. Gölgem Mehmetoğlu’s 🔬 research primarily focuses on musculoskeletal rehabilitation, particularly addressing chronic pain, posture correction, functional mobility, and manual therapy in physiotherapy patients. Her studies emphasize the impact of stabilization exercises 🧘‍♀️ on pain relief, posture (craniovertebral angle 📐), disability reduction, and quality of life 🌿 in conditions like chronic neck pain and lateral epicondylitis. Her work explores the integration of exercise science, biomechanics 🤸, and evidence-based physiotherapy to improve patient outcomes. Through randomized controlled trials and clinical interventions, she contributes valuable knowledge to rehabilitation sciences and therapeutic exercise interventions.

Publication Top Notes

Effect of Postural Stabilization Exercises in Combination with Cervical Stabilization Exercises on Craniovertebral Angle, Pain, Disability, and Quality of Life in Patients with Chronic Neck Pain: A Randomized Controlled Trial

The Effects of Muscle Strength and Muscle Endurance on Upper Extremity Functions of Lateral Epicondylitis Patients

The Pain in the Canon of Medicine: Types, Causes, and Treatment

Serefnur Ozturk | Clinical Trials | Women Researcher Award

Published on by Top Pharmaceutical

Serefnur Ozturk | Clinical Trials | Women Researcher Award

Prof Serefnur Ozturk, Selcuk University Faculty of Medicine, Turkey

Prof. Şerefnur Öztürk is a leading expert in Neurology and Neurointensive Care, currently serving as the Head of the Neurology Department at Selcuk University, Turkey. She has held prominent roles including Vice Dean of the Faculty of Medicine (1996-2020) and President of the Turkish Neurological Society (2014-2021). With significant international influence, she contributes to the European Academy of Neurology and World Stroke Organization. She has led pivotal projects and trials in stroke and COVID-19-related neurological care. Prof. Öztürk is an acclaimed researcher with numerous influential publications in neurology.

Publication Profile

scopus

Education

Prof. Serefnur Ozturk has an impressive educational background. She began her medical studies at Ankara University Medical Faculty, where she earned her degree between 1980 and 1987. Her academic journey continued with a prestigious NATO Fellowship at Arizona University’s Stroke Center in 1993, further enhancing her expertise. In 1998, she advanced her knowledge in neurology and intensive care at Pittsburgh University, where she studied in their renowned Neurology and Intensive Care Department. These experiences have shaped Prof. Ozturk into a leading figure in her field. 🏥🎓🧠

Internship and Residencies

Prof. Serefnur Ozturk completed her internship at Ankara University Medical Faculty, where she gained valuable hands-on experience. Following this, she pursued her residency at Ankara Numune Research and Education Hospital, further honing her medical skills. Prof. Ozturk’s dedication to her field is reflected in her board certification, earning the Turkish Neurological Board Council Certificate. This certification recognizes her extensive expertise in neurology, solidifying her status as a trusted professional in her area of specialization. Her journey through internships, residencies, and board certification showcases her commitment to excellence. 🏥💉🧑‍⚕️🧠

Experiences

Prof. Serefnur Ozturk holds numerous prestigious leadership roles in neurology. She served as the President of the Turkish Neurological Society from 2014 to 2021 and is currently a member of various important committees, including the European Academy of Neurology (EAN) COVID-19 Task Force and the World Stroke Organization Global Policy Committee. Additionally, she is the Vice President of the European Environmental Neurology Society and has held positions within the World Federation of Neurology (WFN), including President of the Migrant Neurology Specialty Group. Prof. Ozturk is dedicated to advancing stroke care, cerebrovascular diseases prevention, and diversity in neurology. 🧠🌍👩‍⚕️🏥

Projects

Prof. Serefnur Ozturk has played a pivotal role in several major clinical trials and registries. She is the Principal Investigator of the EAN ENERGY COVID-19 Registry and the ENSEMBLE study, showcasing her leadership in critical research. Additionally, Prof. Ozturk serves as the National Coordinator for the Turkish COVID-19 Registry, the ENOS Trial, and TICH-2. Her expertise extends to key studies like the PERFORM Study (Phase III), FACT (Phase IV), and NAVIGATE-ESUS, where she also holds significant leadership positions. Her contributions to clinical research have greatly impacted neurology and stroke care. 🔬🧠🌍💉

Research Focus

Prof. Şerefnur Öztürk’s research focus lies predominantly in neurology, with a special emphasis on the neurological impacts of COVID-19, ischemic stroke, and innovative prognostic tools like the Selcuk Score. Her work is pivotal in advancing the understanding of how pandemics influence neurological care and the management of post-pandemic risks. Additionally, Prof. Öztürk contributes to cutting-edge stroke prevention and rehabilitation technologies, including web-based solutions. Her contributions drive progress in neuro-COVID research, stroke management, and global neurological health policies, showcasing her commitment to improving outcomes for patients worldwide. 🌍🧠💻

Publication Top Notes

The European Academy of Neurology NeuroCOVID-19 Task Force: A lesson for the future

Muscle mass as a modifier of stress response in acute ischemic stroke patients

Management of patients with neurological diseases considering post-pandemic coronavirus disease 2019 (COVID-19) related risks and dangers — An updated European Academy of Neurology consensus statement

The Effect of Tranexamic Acid on Neurosurgical Intervention in Spontaneous Intracerebral Hematoma: Data from 121 Surgically Treated Participants from the Tranexamic Acid in IntraCerebral Hemorrhage-2 Randomized Controlled Trial

General neurology: Current challenges and future implications

Climate Change and Stroke: A Topical Narrative Review